Codexis
Logotype for Codexis Inc

Codexis (CDXS) investor relations material

Codexis Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Codexis Inc
Q4 2025 earnings summary11 Mar, 2026

Executive summary

  • Achieved pivotal milestones in 2025, advancing the ECO Synthesis platform from concept to viable business, supporting preclinical development and customer IND submissions.

  • Fourth quarter 2025 revenue reached $38.9 million, with full-year revenue at $70.4 million, up 19% year-over-year, driven by the Merck agreement and higher R&D revenue.

  • Completed a $37.8 million Technology Transfer Agreement with Merck, significantly boosting Q4 revenue and validating commercial interest.

  • Ended 2025 with $78.2 million in cash and equivalents, providing runway through 2027.

  • Secured multiple contracts with leading pharma, biotech, and CDMOs, expanding commercial reach and supporting profit margins.

Financial highlights

  • FY 2025 revenue reached $70.4M, up from $59.3M in 2024; Q4 2025 revenue was $38.9M, up from $21.5M in Q4 2024.

  • Product gross margin improved to 64% for FY25 (from 56% in FY24) and 65% in Q4 2025 (from 63% in Q4 2024).

  • FY25 net loss narrowed to $44.0 million, improved from $65.3 million loss in 2024; Q4 2025 net income was $9.6 million versus a $10.4 million loss in Q4 2024.

  • R&D expenses: $11.7M in Q4 2025 ($52.3M FY), up from $12.1M Q4 2024 ($46.3M FY 2024); SG&A expenses: $11.2M in Q4 2025 ($47.1M FY), down from $13M Q4 2024 ($55.1M FY 2024).

  • One-time restructuring charge of $3.4M in Q4 and FY25.

Outlook and guidance

  • 2026 revenue guidance is $72M–$76M, with revenue expected to be weighted toward the second half of the year.

  • Gross margins expected to remain stable at 2025 levels; operating expenses and CapEx to be similar to 2025.

  • Cash position expected to fund operations through end of 2027.

  • Focus on signing new licensing deals, scaling up ECO Synthesis, and progressing customer contracts to multi-year agreements.

  • GMP facility retrofit to begin in H2 2026, with full production by end of 2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Codexis earnings date

Logotype for Codexis Inc
Q1 202613 May, 2026
Codexis
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Codexis earnings date

Logotype for Codexis Inc
Q1 202613 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Codexis, Inc. discovers, develops, and sells enzymes and other proteins to the pharmaceutical and renewable chemical industries. The company offers CodeEvolver protein engineering platform that involves designing of molecule, designing an enzyme to do the job, and optimizing the enzyme for industrial use in discovery drug safety evaluations (DSEs) market; CodeXyme enzyme for converting sugar into specialty chemicals; and enzymes for manufacturing APIs. It also provides enzymes for fuel ethanol industry.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage